| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Article |
Bone Mineral Research Center (S.A., S.P., J.Y., J.F.A.), Winthrop-University Hospital, Mineola, New York 11501; State University of New York at Stony Brook (J.F.A.), Stony Brook, New York 11790; and St. Johns University (S.P.), Jamaica, New York 11439
Address all correspondence and requests for reprints to: John F. Aloia, M.D., Winthrop-University Hospital, 259 First Street, Mineola, New York 11501.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
The first evidence of a relationship between vitamin D and body fat was described by Lumb et al. (6) in 1971. They hypothesized that vitamin D after absorption is sequestered and stored in tissues like fat and muscle and then released slowly into the circulation in which it is used biologically. Later the same group (7) demonstrated by injecting radioactively labeled vitamin D3 in 60 individuals in whom the highest concentration of biological activity and radioactivity was seen in fat tissue. Similar evidence was found in animal models confirming that adipose tissue is the major storage site for vitamin D3 and a source available for conversion to other metabolites during deprivation (8). A subsequent study on morbidly obese subjects also suggested that decline in 25-OHD levels in obesity may be secondary to alteration in tissue distribution resulting from increase in adipose mass (4). More recently, Worstman et al. (9) confirmed that obesity-associated vitamin D insufficiency most likely is due to decreased bioavailability of vitamin D3 from cutaneous and dietary sources because of its deposition in body fat compartments. Based on this evidence, it is expected that obese individuals need higher-than-usual doses of vitamin D for supplementation.
However, it still remains unclear whether adiposity (or percentage body fat) should be taken into consideration while assessing vitamin D requirements in the general population. We studied the relationship between 25-OHD levels and the percentage body fat content in healthy women from our community who ranged from lean to mildly obese. We also analyzed the influence of season, dietary vitamin D intake, age, race, and smoking on this correlation.
| Subjects and Methods |
|---|
|
|
|---|
Each participant had a total body scan using dual-energy x-ray absorptiometry (DXA) with a radiation densitometer (model DPX-L, software program 1.3Y, Lunar Corp., Madison, WI). Kilograms of total body fat and nonfat soft tissue weight were estimated by DXA on total body scan. Percentage body fat (%TBF) by DXA was calculated as [fat mass (g)/fat mass (g) + lean mass (g) + total bone mineral content (g)] x 100.
Blood samples were collected after an overnight fast for serum calcium, phosphorus, and 25-OHD. Serum 25-OHD was measured by RIA using a kit (DiaSorin, Inc. Corp., Stillwater, MN). The coefficient of variation for intraassay was 4.1% and interassay was 7.0%. Serum calcium was measured by atomic absorption spectrophotometry (model 560, Perkin Elmer Corp., Norwalk, CT). Serum inorganic phosphate was measured colorimetrically.
Statistical analysis
Some of the known influences on 25-OHD levels include season, race, age, and dietary vitamin D. In examining the relationship between 25-OHD levels and the percentage body fat, we statistically controlled for these variables in a multiple regression model, including them as covariates. In addition, we looked at univariate linear predictors of 25-OHD.
To study seasonal variation in New York (latitude 40 degrees, 42 min, 51 sec north; longitude 74 degrees, 0 min, 23 sec west), we subdivided the year into 4-month measurement periods: February-May, June-September, and October-January (11). These periods roughly approximate the seasonal changes in availability of sunlight (measurement of both direct and diffuse solar radiation assessed by pyranometers) throughout a year in the New York area. The amount of daily and seasonal solar radiation available at this latitude varies significantly among the three seasons defined above (12).
Statistical analyses were generated by SAS version 8.1 (SAS Institute, Inc., Cary, NC). Because nonparametric and parametric results were similar, only parametric results were reported. For purposes of reporting descriptive statistics, 25-OHD results were stratified by race and season. A nominal significance level of 0.05 (two-tailed) was used throughout. A stepwise multiple regression was run to determine whether other anthropometric variables were associated with 25-OHD. The significance level criterion for stepwise inclusion into the multiple regression model was 0.10. In addition to total body fat, other anthropometric measures like body weight, height, and BMI were included. These analyses were also controlled for race, season, age, and dietary vitamin D.
| Results |
|---|
|
|
|---|
|
|
Race, season, age, and dietary vitamin D were significant variables, in a bivariate analysis, predicting serum calcidiol levels in our population. Therefore, we statistically controlled for these variables to study the impact of %TBF on serum calcidiol levels. We found a significant linear negative correlation between 25-OHD levels and %TBF in the study population after adjusting for race, season, age, and dietary vitamin D. The partial correlation with %TBF was -0.13 (P = 0.013, Table 2
). The levels of 25-OHD inversely correlated with BMI as well, although this was not statistically significant. We did not find a significant correlation between cigarette smoking and serum 25-OHD levels in the few smokers (n = 40) in our population (r = 0.002, P = ns).
|
|
| Discussion |
|---|
|
|
|---|
The mechanism of variations in serum 25-OHD levels in both nonobese and obese individuals appears to be related to availability of adipose tissue leading to excessive storage of the precursor in the fat tissue. Some investigators (4) had suggested that serum 25-OHD increases appropriately in response to UV radiation in obese individuals, implying that low vitamin D levels do not result from impaired dermal production and delivery. A recent study by Worstman et al. (9) contradicts this statement. In dynamic testing on 13 obese (BMI > 30) white individuals and 13 controls to evaluate the blood levels of vitamin D and its response after exposure to UV-B radiation or an oral dose of vitamin D2, they reported that the increase in vitamin D3 levels was 57% less in the obese than in nonobese subjects post irradiation to UVB rays. This suggests that the sc fat, which is known to store vitamin D3, sequestered more of the synthesized vitamin D3 in the obese than in the nonobese subjects because there was more fat available for this process. In contrast, supplementation with 50,000 IU oral vitamin D2 resulted in an increase in serum vitamin D2 levels in both obese and nonobese individuals with no significant difference between the peak serum vitamin D2 levels in the two groups. The results of this study not only imply that obesity is associated with lower vitamin D levels secondary to the increase in adiposity but also suggest that oral vitamin D supplementation, in high doses, may be more bioavailable to obese individuals for conversion into 25-OHD, compared with vitamin D synthesized in the dermis.
Although Scragg et al. (17) had reported no correlation between serum vitamin D levels and BMI in a cross-sectional study of the healthy population in New Zealand, there is also evidence that indicates that increasing adiposity causes relative resistance to standard doses of vitamin D, i.e. the serum levels of 25-OHD do not rise as much in thinner individuals. In a study by Barger-Lux et al. (18), oral vitamin D3 was given in graded doses to nonobese men aged 2037 yr and the factors influencing the serum 25-OHD response to a given dose of vitamin D3 were determined. Besides the dose of oral vitamin D3 and basal level of serum 25-OHD, BMI, not weight, contributed significantly to the variance in 25-OHD response in an inverse relationship (<0.05). We analyzed our data to predict serum 25-OHD levels based on the daily dietary vitamin D intake per kilogram of body weight of the subjects. The results could be expressed as serum 25-OHD (nanomoles per liter) = 48.8 + 127.1 [dietary vitamin D (in micrograms per day) per kilogram body weight]. This relationship is significant at P less than 0.01. We did not find as strong a correlation between serum 25-OHD levels and the vitamin D intake/kg/day as the previous study by Barger-Lux et al. (18) The rather small r2 could be from several differences in our study compared with Barger-Lux et al. Our data analysis is cross-sectional and the range of dietary vitamin D intake in the study subjects was very small (with a mean of 2.7 µg/d ± 2.4 µg/d). Dietary vitamin D assessment was based on a recall method that gives only a rough estimate. Variations in the estimate of vitamin D intake derived from the 24-hr recall method may obscure significant relationships (19). Finally, our correlation is based on baseline dietary vitamin D consumption rather than oral vitamin D supplementation in a controlled fashion. Nevertheless, both these studies indicate that body weight, or more specifically body fat, have a significant influence on the serum 25-OHD levels not only in obese subjects but also in a healthy population.
The effect of seasonal changes on the serum 25-OHD levels was seen in the whole population but was less pronounced in blacks compared with white women. The peak levels were achieved during summer months when the sun exposure is greatest. As is well known cutaneous synthesis of vitamin D occurs through photoconversion of 7-dehydrocholesterol to precholecalcifeol at wavelengths of light between 290315 nm (20). Thermal isomerization of precholecalciferol to cholecalciferol occurs with about 50% of precholecalciferol (previtamin D3) converting to cholecalciferol (vitamin D3) over a three day period. During the winter months sunlight is filtered at a more oblique angle through the stratospheric ozone layer, decreasing the UVB radiation (responsible for previtamin D3 production) that reaches the earths surface resulting in marked changes in the cutaneous vitamin D3 synthesis varying with different latitudes (21). Some other factors that could effect cutaneous previtamin D3 production include melanin (22) and aging (23). Katz et al. (24) prospectively measured seasonal changes in black adults. In this study, nine black men and women from South Carolina had increases in serum 25-OHD levels that were half those of the six white subjects. Similar racial differences have been reported by Scragg et al. (17) in New Zealand, and Harris and Dawson-Hughes (25) in Boston. In that study, 51 young black and 39 white women were studied longitudinally. The results were similar to our study. Both groups showed seasonal variation in 25-OHD concentrations, including the fact that the amplitude of change, i.e. summertime increase, was lower in black than white women. When UV exposure is sufficient, black adult populations can achieve mean concentrations of both vitamin D and 25-OHD that are similar to those of whites (26, 27). Thus, it appears that the more pigmented skin of black women allowed them to form substantially less previtamin D during summer months resulting in lower stores of previtamin D for conversion to vitamin D (22). There is also some suggestion that black women may also store less previtamin D, vitamin D, or vitamin D metabolites in body tissues for several months beyond the synthesis phase (5, 28), although definitive studies need to be done for this to be established.
The influence of age on 25-OHD has also been previously studied (23, 28, 29). The absolute concentration of 7-dehydrocholesterol (provitamin D3) in the skin decreases with age. Aging per se does not appear to significantly alter the efficiency of conversion of provitamin D3 to previtamin D3 and vitamin D3 (23). Also, older people tend to have lower dietary vitamin D intake and less exposure to sunlight. These observations are especially important for the elderly who rely on exposure to sunlight for their vitamin D requirements. If sufficient stores are not built up in the fat during summer months, it is likely that without vitamin D supplementation the elderly people will be at risk for developing vitamin D deficiency because exposure to sunlight during winter is ineffective for producing vitamin D3 in skin. Absorption of vitamin D from the gut is not impaired by aging (28, 29), but dietary intake is often reduced.
In conclusion, this study suggests that percentage body fat is independently associated with serum levels of 25-OHD in healthy women besides other well-known factors such as dietary vitamin D intake, season, age, and race. Although the impact of body fat is relatively small, it is statistically significant and may influence the way we assess vitamin D nutrition and recommend supplementation in healthy women. Because optimal vitamin D nutrition is one of the goals to improve skeletal health, vitamin D supplementation may be a norm, especially during winter months for women living at higher latitudes. It is now an emerging consensus that 25-OHD level of at least 80 nmol/liter may be needed to ensure vitamin D sufficiency and prevent secondary hyperparathyroidism and its consequences on bone metabolism (30). It is clear from our study that greater the body fat, the increased likelihood of failing to achieve an optimal 25-OHD of 80 nmol/liter, even during summer when it should be relatively easy to maintain blood levels, independent of race.
A remedy for this inadequacy may be oral vitamin D supplementation in women. Our study suggests that individuals with higher percentage body fat may require higher vitamin D intake to attain optimal 25-OHD levels, compared with lean individuals; therefore, body fat should be taken into consideration when assessing vitamin D requirements. But the exact impact of body fat on oral vitamin D supplementation to optimize 25-OHD could be obtained only from a longitudinal study with vitamin D supplementation. Needless to say, what seems to be a small correlation in our cross-sectional study may in fact have a greater impact when assessed in a controlled longitudinal study with vitamin D supplementation. Therefore, we think that a longitudinal study of oral vitamin D supplementation in the general population will be necessary before this information could be applied clinically.
| Acknowledgments |
|---|
| Footnotes |
|---|
Abbreviations: 25-OHD, 25-Hydroxyvitamin D; BMI, body mass index; DXA, dual-energy x-ray absorptiometry; %TBF, percentage body fat; TBF, total body fat mass.
Received June 25, 2002.
Accepted October 3, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. M. Bodnar, J. M. Catov, J. M. Roberts, and H. N. Simhan Prepregnancy Obesity Predicts Poor Vitamin D Status in Mothers and Their Neonates J. Nutr., November 1, 2007; 137(11): 2437 - 2442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Bolland, A. B Grey, R. W Ames, B. H Mason, A. M Horne, G. D Gamble, and I. R Reid The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency Am. J. Clinical Nutrition, October 1, 2007; 86(4): 959 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reinehr, G. de Sousa, U. Alexy, M Kersting, and W. Andler Vitamin D status and parathyroid hormone in obese children before and after weight loss Eur. J. Endocrinol., August 1, 2007; 157(2): 225 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Martins, M. Wolf, D. Pan, A. Zadshir, N. Tareen, R. Thadhani, A. Felsenfeld, B. Levine, R. Mehrotra, and K. Norris Prevalence of Cardiovascular Risk Factors and the Serum Levels of 25-Hydroxyvitamin D in the United States: Data From the Third National Health and Nutrition Examination Survey Arch Intern Med, June 11, 2007; 167(11): 1159 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Tworoger, I-M. Lee, J. E. Buring, B. Rosner, B. W. Hollis, and S. E. Hankinson Plasma 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D and Risk of Incident Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 783 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M van Dam, M. B Snijder, J. M Dekker, C. D. Stehouwer, L. M Bouter, R. J Heine, and P. Lips Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study Am. J. Clinical Nutrition, March 1, 2007; 85(3): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A Camargo Jr, S. L Rifas-Shiman, A. A Litonjua, J. W Rich-Edwards, S. T Weiss, D. R Gold, K. Kleinman, and M. W Gillman Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age Am. J. Clinical Nutrition, March 1, 2007; 85(3): 788 - 795. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hypponen and C. Power Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors Am. J. Clinical Nutrition, March 1, 2007; 85(3): 860 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N Hathcock, A. Shao, R. Vieth, and R. Heaney Risk assessment for vitamin D Am. J. Clinical Nutrition, January 1, 2007; 85(1): 6 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hypponen and C. Power Vitamin D Status and Glucose Homeostasis in the 1958 British Birth Cohort: The role of obesity Diabetes Care, October 1, 2006; 29(10): 2244 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Rockell, T. J. Green, C. M. Skeaff, S. J. Whiting, R. W. Taylor, S. M. Williams, W. R. Parnell, R. Scragg, N. Wilson, D. Schaaf, et al. Season and Ethnicity Are Determinants of Serum 25-Hydroxyvitamin D Concentrations in New Zealand Children Aged 5-14 y J. Nutr., November 1, 2005; 135(11): 2602 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Panidis, C. Balaris, D. Farmakiotis, D. Rousso, A. Kourtis, V. Balaris, I. Katsikis, V. Zournatzi, and E. Diamanti-Kandarakis Serum Parathyroid Hormone Concentrations Are Increased in Women with Polycystic Ovary Syndrome Clin. Chem., September 1, 2005; 51(9): 1691 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Snijder, R. M. van Dam, M. Visser, D. J. H. Deeg, J. M. Dekker, L. M. Bouter, J. C. Seidell, and P. Lips Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4119 - 4123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Looker Body Fat and Vitamin D Status in Black Versus White Women J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 635 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Manco, M. Calvani, and G. Mingrone How to consider low serum vitamin D as a risk factor for insulin resistance? Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1450 - 1451. [Full Text] [PDF] |
||||
![]() |
C. M. Gordon, K. C. DePeter, H. A. Feldman, E. Grace, and S. J. Emans Prevalence of Vitamin D Deficiency Among Healthy Adolescents Arch Pediatr Adolesc Med, June 1, 2004; 158(6): 531 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Parikh, M. Edelman, G. I. Uwaifo, R. J. Freedman, M. Semega-Janneh, J. Reynolds, and J. A. Yanovski The Relationship between Obesity and Serum 1,25-Dihydroxy Vitamin D Concentrations in Healthy Adults J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1196 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Bakalov, L. Axelrod, J. Baron, L. Hanton, L. M. Nelson, J. C. Reynolds, S. Hill, J. Troendle, and C. A. Bondy Selective Reduction in Cortical Bone Mineral Density in Turner Syndrome Independent of Ovarian Hormone Deficiency J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5717 - 5722. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |